abstract |
ABSTRACT OF THE DISCLOSURE New 1-(N-acylcarbamoyl)-2-cyanoaziridines and processes for their preparation are provided, the new compounds are of formula the new compounds and their salts are cancerostatic and immuna-stimulating therapeutic compounds of good stability and low toxicity which can be administered orally. |